Vera Therapeutics
VERA
30.25
+0.83
+2.82%
Vera Therapeutics
US · VERA
#2739 by market cap
Listed 2021
30.25
+0.83
+2.82%
Live - 5344 symbols - heartbeat 404s ago
· 2026-10-08 04:00
Pre-market
30.25
0.00%
After-hours
30.00
-0.83%
- Market cap
- 2.18B
- P/E (TTM)i
- -5.15
- P/Bi
- 5.35
- EPSi
- -4.66
- Div yieldi
- 0.00%
- 52W posi
- 22%
Reader sentiment
Are you bullish or bearish on VERA?
Anonymous reader poll. Unscientific, not investment advice.
About Vera Therapeutics
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
- Founded
- 2016
- CEO
- Dr. Marshall Fordyce, M.D.
- Employees
- 249
- Headquarters
- Brisbane, California, United States of America
- Fiscal year end
- 12-31
- Website
- veratx.com
Company profile
- Exchange
- US
- Symbol
- VERA
- Market-cap rank
- #2739
- Listing date
- 2021-05-14
- Market cap
- 2.18B
- Float cap
- 1.58B
- Shares out
- 72.06M
- Float shares
- 52.39M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 04:00:01 · For reference only, not investment advice and not tailored to your situation.